3D printing is an emerging field in the medical industry contributing to various technological innovations. It allowed developers to design 3D-printed skin grafts by eliminating the need to create artificial grafts. In 2019, technological developments enabled Rensselaer Polytechnic Institute, New York, researchers to innovate 3D printing of living skin with complete blood vessels. It is expected that 3D-printed living skin will allow patients to undergo skin grafting without suffering secondary wounds created during surgical procedures. However, the 3D-printed living skin is under clinical trials, and much more work is needed before the commercial application of 3D-printed living skin for human use.
Significant progress has been made to use 3D-printed living skin to treat diabetes and pressure ulcers or wounds. It is also expected that 3D-printed living skin will reduce the risk of complications and address aesthetic concerns with ease. According to the researchers for Rensselaer Polytechnic Institute, the 3D-printed living skin will be more like a fancy band-aid that will accelerate wound healing with much more reduced time. Thus, such innovations in skin grafts are likely to enhance the growth opportunities for market players to commercialize 3D-printed skin grafts and contribute to the market's growth in the coming future. Also, the alternative sources of skin grafts further aid in the growth of skin grafting practices and procedures, thereby driving the growth of the skin grafting system market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA skin grafting system market in the coming years. The market is expected to grow at a good CAGR during the forecast period.
MEA Skin Grafting System Market Segmentation
The MEA skin grafting system market is segmented on the basis of product type, type, wound type, end user, and country. The market, based on product type, is segmented into dermatomes, wound debridement devices, skin graft mesher equipment and accessories, and others. The wound debridement devices segment held the largest share of the market in 2021. Based on type, the MEA skin grafting system market is bifurcated into autograft and allograft. The autograft segment held a larger share of the market in 2021 and is expected to hold a significant share of the market during the forecast period. Based on wound type, the market is segmented into burns, chronic wounds, traumatic wounds, surgical wounds, and others. The burns segment is expected to hold the largest market share during the forecast period. Based on end user, the MEA skin grafting system market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment held the largest share of the market and is expected to register the highest CAGR during the forecast period. Based on country, the MEA skin grafting system market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA.
Aygun Surgical Instruments Co., Inc.; B. De Soutter Medical; Humeca BV; Integra Lifesciences Holdings Corp.; Lutz GmbH & Co. KG; Smith & Nephew; Stryker Corp.; and Zimmer Biomet are among the leading companies in the MEA skin grafting system market.